BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11285156)

  • 1. Tattoos as risk factors for transfusion-transmitted diseases.
    Nishioka S; Gyorkos TW
    Int J Infect Dis; 2001; 5(1):27-34. PubMed ID: 11285156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tattooing and risk for transfusion-transmitted diseases: the role of the type, number and design of the tattoos, and the conditions in which they were performed.
    Nishioka Sde A; Gyorkos TW; Joseph L; Collet JP; Maclean JD
    Epidemiol Infect; 2002 Feb; 128(1):63-71. PubMed ID: 11895092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tattooing and transfusion-transmitted diseases in Brazil: a hospital-based cross-sectional matched study.
    de Nishioka SA; Gyorkos TW; Joseph L; Collet JP; MacLean JD
    Eur J Epidemiol; 2003; 18(5):441-9. PubMed ID: 12889691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of transfusion-transmitted diseases among people with tattoos: A systematic review and meta-analysis.
    Lim SH; Lee S; Lee YB; Lee CH; Lee JW; Lee SH; Lee JY; Kim JS; Park MY; Koh SB; Choi EH
    PLoS One; 2022; 17(1):e0262990. PubMed ID: 35085358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in major transfusion-transmissible infections among blood donors over 17 years in Istanbul, Turkey.
    Kocak N; Hepgul S; Ozbayburtlu S; Altunay H; Ozsoy MF; Kosan E; Aksu Y; Yilmaz G; Pahsa A
    J Int Med Res; 2004; 32(6):671-5. PubMed ID: 15587762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tattoos and transfusion-transmitted disease risk: implications for the screening of blood donors in Brazil.
    Nishioka Sde A; Gyorkos TW; MacLean JD
    Braz J Infect Dis; 2002 Aug; 6(4):172-80. PubMed ID: 12204184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious complications of tattoos.
    Long GE; Rickman LS
    Clin Infect Dis; 1994 Apr; 18(4):610-9. PubMed ID: 8038318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso.
    Kania D; Sangaré L; Sakandé J; Koanda A; Nébié YK; Zerbo O; Combasséré AW; Guissou IP; Rouet F
    Transfusion; 2009 Oct; 49(10):2237-40. PubMed ID: 19903285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual transmission of hepatitis B in Mwanza, Tanzania.
    Jacobs B; Mayaud P; Changalucha J; Todd J; Ka-Gina G; Grosskurth H; Berege ZA
    Sex Transm Dis; 1997 Mar; 24(3):121-6. PubMed ID: 9132977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of transfusion transmitted infection among blood donors at Jijiga blood bank, Eastern Ethiopia: retrospective 4 years study.
    Mohammed Y; Bekele A
    BMC Res Notes; 2016 Feb; 9():129. PubMed ID: 26922241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C; Araújo F
    Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of transfusion-transmitted infections in sub-Saharan Africa.
    Jayaraman S; Chalabi Z; Perel P; Guerriero C; Roberts I
    Transfusion; 2010 Feb; 50(2):433-42. PubMed ID: 19843290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.
    Soldan K; Barbara JA; Ramsay ME; Hall AJ
    Vox Sang; 2003 May; 84(4):274-86. PubMed ID: 12757501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of a national serological survey for diseases transmitted by blood transfusion].
    Pérez Bianco R; Santarelli MT
    Medicina (B Aires); 1993; 53(6):491-6. PubMed ID: 8084245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for transfusion-transmitted infectious diseases in Central and South America.
    Schmunis GA; Zicker F; Pinheiro F; Brandling-Bennett D
    Emerg Infect Dis; 1998; 4(1):5-11. PubMed ID: 9452393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfusion-induced virus infections: how great is the risk?].
    Sibrowski W; Penner M; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between screening and confirmatory serological assays in blood donors in a region of South Italy.
    Sommese L; Iannone C; Cacciatore F; De Iorio G; Napoli C
    J Clin Lab Anal; 2014 May; 28(3):198-203. PubMed ID: 24478048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of blood supply for infectious diseases in Latin American countries, 1994-1997.
    Schmunis GA; Zicker F; Cruz JR; Cuchi P
    Am J Trop Med Hyg; 2001 Dec; 65(6):924-30. PubMed ID: 11792000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.